Status:
TERMINATED
EBUS-Miniprobes Sampling for Peripheral Lung Lesions
Lead Sponsor:
Centre Hospitalier Universitaire Saint Pierre
Conditions:
Lung Cancer
Peripheral Pulmonary Lesions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is an interest in characterazing asymptomatic peripheral lung lesions beacause they could be an early form of neoplasm. These lesions are invisible in the endoscopic exam, so the samples must b...
Detailed Description
Because of the more frequent use of thoracic imaging by ct-scan, there are a growing number of asymptomatic peripheral lung lesions that are revealed. As they could be a be an early form of pulmonary...
Eligibility Criteria
Inclusion
- Patients presenting a peripheral lung lesion having given their approval
Exclusion
- Lung lesion who according to ct Scan has a greater diameter lesser than 10 mm
- Ground glass lesion
- Lesion that are suspected to be a bronchopneumonia
- Contra-indication for endoscopic exam ( uncontrolled hypoxia, hypercapnia, sympotmatic bronchial hyperreactivity, recent myocardial infarction, heart failure)
- contra-indication for a transbronchial biopsy ( coagulapathy iatrogenic or not, recent uptake of anitaggregant medicines)
Key Trial Info
Start Date :
August 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03422744
Start Date
August 3 2017
End Date
September 30 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHu Saint Pierre
Brussels, Belgium, 1000